161 related articles for article (PubMed ID: 21380606)
1. Urinary excretion profiles of toremifene metabolites by liquid chromatography-mass spectrometry. Towards targeted analysis to relevant metabolites in doping control.
Mazzarino M; de la Torre X; Botrè F
Anal Bioanal Chem; 2011 Aug; 401(2):529-41. PubMed ID: 21380606
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometric characterization of urinary toremifene metabolites for doping control analyses.
Gómez C; Pozo OJ; Diaz R; Sancho JV; Vilaroca E; Salvador JP; Marco MP; Hernandez F; Segura J; Ventura R
J Chromatogr A; 2011 Jul; 1218(29):4727-37. PubMed ID: 21683367
[TBL] [Abstract][Full Text] [Related]
3. A mass spectrometric approach for the study of the metabolism of clomiphene, tamoxifen and toremifene by liquid chromatography time-of-flight spectroscopy.
Mazzarino M; Fiacco I; de la Torre X; Botrè F
Eur J Mass Spectrom (Chichester); 2008; 14(3):171-80. PubMed ID: 18708697
[TBL] [Abstract][Full Text] [Related]
4. Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry.
Thomas A; Höppner S; Geyer H; Schänzer W; Petrou M; Kwiatkowska D; Pokrywka A; Thevis M
Anal Bioanal Chem; 2011 Aug; 401(2):507-16. PubMed ID: 21298258
[TBL] [Abstract][Full Text] [Related]
5. Screening for benfluorex and its major urinary metabolites in routine doping controls.
Thevis M; Sigmund G; Gougoulidis V; Beuck S; Schlörer N; Thomas A; Kwiatkowska D; Pokrywka A; Schänzer W
Anal Bioanal Chem; 2011 Aug; 401(2):543-51. PubMed ID: 21116611
[TBL] [Abstract][Full Text] [Related]
6. Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research.
Beuck S; Bornatsch W; Lagojda A; Schänzer W; Thevis M
Drug Test Anal; 2011; 3(11-12):756-70. PubMed ID: 22213684
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometric characterization of toremifene metabolites in human urine by liquid chromatography-tandem mass spectrometry with different scan modes.
Lu J; Wang X; Xu Y; Dong Y; Yang S; Wu Y; Qin Y; Wu M
Analyst; 2011 Feb; 136(3):467-72. PubMed ID: 21113546
[TBL] [Abstract][Full Text] [Related]
8. Metabolic study of androsta-1,4,6-triene-3,17-dione in horses using liquid chromatography/high resolution mass spectrometry.
Kwok WH; Leung GN; Wan TS; Curl P; Schiff PJ
J Steroid Biochem Mol Biol; 2015 Aug; 152():142-54. PubMed ID: 26031748
[TBL] [Abstract][Full Text] [Related]
9. Alternative long-term markers for the detection of methyltestosterone misuse.
Gómez C; Pozo OJ; Marcos J; Segura J; Ventura R
Steroids; 2013 Jan; 78(1):44-52. PubMed ID: 23127819
[TBL] [Abstract][Full Text] [Related]
10. Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls.
Sigmund G; Dib J; Tretzel L; Piper T; Bosse C; Schänzer W; Thevis M
Drug Test Anal; 2015; 7(11-12):1057-62. PubMed ID: 26481102
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the biotransformation pathways of clomiphene, tamoxifen and toremifene as assessed by LC-MS/(MS) following in vitro and excretion studies.
Mazzarino M; Biava M; de la Torre X; Fiacco I; Botrè F
Anal Bioanal Chem; 2013 Jun; 405(16):5467-87. PubMed ID: 23604525
[TBL] [Abstract][Full Text] [Related]
12. Carbon isotope ratio analysis of endogenous glucocorticoid urinary metabolites after cortisone acetate and adrenosterone administration for doping control.
Brooker L; Cawley A; Kazlauskas R; Goebel C; George A
Drug Test Anal; 2012 Dec; 4(12):951-61. PubMed ID: 22987608
[TBL] [Abstract][Full Text] [Related]
13. Revisiting the metabolism of 19-nortestosterone using isotope ratio and high resolution/high accuracy mass spectrometry.
Piper T; Schänzer W; Thevis M
J Steroid Biochem Mol Biol; 2016 Sep; 162():80-91. PubMed ID: 26699683
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen isotope ratio mass spectrometry and high-resolution/high-accuracy mass spectrometry in metabolite identification studies: detecting target compounds for sports drug testing.
Thevis M; Piper T; Horning S; Juchelka D; Schänzer W
Rapid Commun Mass Spectrom; 2013 Sep; 27(17):1904-12. PubMed ID: 23939956
[TBL] [Abstract][Full Text] [Related]
15. Screening and confirmation capabilities of liquid chromatography-time-of-flight mass spectrometry for the determination of 200 multiclass sport drugs in urine.
Domínguez-Romero JC; García-Reyes JF; Lara-Ortega FJ; Molina-Díaz A
Talanta; 2015 Mar; 134():74-88. PubMed ID: 25618643
[TBL] [Abstract][Full Text] [Related]
16. Elucidation of urinary metabolites of fluoxymesterone by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry.
Pozo OJ; Van Thuyne W; Deventer K; Van Eenoo P; Delbeke FT
J Mass Spectrom; 2008 Mar; 43(3):394-408. PubMed ID: 18035854
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of urinary prenylamine metabolites by means of liquid chromatography-tandem mass spectrometry.
Beuck S; Sigmund G; Koch A; Schänzer W; Pokrywka A; Kwiatkowska D; Thevis M
Drug Test Anal; 2012 Sep; 4(9):701-16. PubMed ID: 22786790
[TBL] [Abstract][Full Text] [Related]
18. Complementing the characterization of in vivo generated N-glucuronic acid conjugates of stanozolol by collision cross section computation and analysis.
Thevis M; Dib J; Thomas A; Höppner S; Lagojda A; Kuehne D; Sander M; Opfermann G; Schänzer W
Drug Test Anal; 2015; 7(11-12):1050-6. PubMed ID: 26514814
[TBL] [Abstract][Full Text] [Related]
19. A novel HPLC-MRM strategy to discover unknown and long-term metabolites of stanozolol for expanding analytical possibilities in doping-control.
Wang Z; Zhou X; Liu X; Dong Y; Zhang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():250-259. PubMed ID: 27842983
[TBL] [Abstract][Full Text] [Related]
20. New clostebol metabolites in human urine by liquid chromatography time-of-flight tandem mass spectrometry and their application for doping control.
Lu J; Fernández-Álvarez M; Yang S; He G; Xu Y; Aguilera R
J Mass Spectrom; 2015 Jan; 50(1):191-7. PubMed ID: 25601692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
